Alphatec (ATEC) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
29 Apr, 2026Executive summary
Annual meeting scheduled for June 10, 2026, at the company’s headquarters in Carlsbad, CA.
Proxy materials are available online, with options to request paper or email copies by May 29, 2026.
Voting matters and shareholder proposals
Election of seven directors is up for shareholder vote.
Ratification of Deloitte & Touche LLP as independent auditor for fiscal year ending December 31, 2026.
Approval sought for the 2026 Equity Incentive Plan.
Approval sought for the 2026 Employee Stock Purchase Plan.
Advisory vote on executive compensation (say-on-pay) included.
Board of directors and corporate governance
Seven nominees listed for election to the board, including Mortimer Berkowitz III, Quentin Blackford, David Demski, Karen K. McGinnis, Patrick S. Miles, David R. Pelizzon, and Keith Valentine.
Latest events from Alphatec
- Q1 2026 revenue up 14% to $192M, with EBITDA doubling and debt costs set to drop $6M+.ATEC
Q1 202611 May 2026 - Shareholders will vote on directors, auditor, equity plans, and executive pay, with board support.ATEC
Proxy filing29 Apr 2026 - 2025 revenue up 25% to $764M; 2026 guidance raised to $890M and $134M adjusted EBITDA.ATEC
Q4 20259 Apr 2026 - Surgeon adoption, enabling tech, and disciplined capital deployment drive robust growth and share gains.ATEC
Barclays 28th Annual Global Healthcare Conference11 Mar 2026 - Q3 2024 revenue up 27%, adjusted EBITDA positive, and liquidity boosted by $50M term loan.ATEC
Q3 202413 Feb 2026 - Q2 revenue up 25% to $146M, margin expansion, positive EBITDA, and guidance raised.ATEC
Q2 202413 Feb 2026 - Rapid growth driven by procedural innovation, margin leverage, and targeted expansion.ATEC
Jefferies Global Healthcare Conference1 Feb 2026 - Spine-focused innovation and informatics drive strong growth, profitability, and global expansion.ATEC
44th Annual J.P. Morgan Healthcare Conference30 Jan 2026 - Inventory investment to decline, supporting free cash flow break even in 2025 and robust growth.ATEC
2024 Wells Fargo Healthcare Conference22 Jan 2026